News & updates

TU Delft | Global Initiative and LUMC Global kick off the new Interdisciplinary Research Workshop ‘Housing and Health’

Created on:


October 11, 2021

Together with the TU Delft | Global Initiative, LUMC Global has set up a collaborative research workshop which kicks off today. Students enrolled in the workshop will partake in a study to primarily analyze the correlation between spatial conditions of residential neighbourhoods and buildings, and health. They will develop a comparative analysis of two neighbourhoods in The Hague.

The course will run from October 11th till November 12th and will give students the opportunity to collaborate interdisciplinary on a relevant societal research project. Students from TUD, LUMC and LCAB (Leiden Centre for Applied Bioscience) will join forces and conduct fieldwork at community houses in specifically selected neighbourhoods in The Hague. Fieldwork will include recruiting residents to participate in the study, data collection and interviews, the collection of air samples and result analysis using the 5 dimensions on the Leefbarometer.

The collaborative educational initiative between LUMC and TU Delft hopefully marks the first of many and we’re thrilled to have initiated this project together. The interdisciplinary approach is set to cross borders in the future once the pandemic allows it, but we’re very proud to have started this project locally, letting students contribute to research projects that will hopefully benefit global healthcare.

“Our students and teachers are so brave to take on this exciting challenge!”, says Prof Maria Yazdanbakhsh, chair of the LUMC Global initiative and one of the initiators of the project. “Without the medical and social sciences we can’t make sense of what we’re doing when we’re thinking about how to design houses and cities”, adds Prof Dick van Gameren, dean of the Faculty of Architecture and the Built Environment and allied with the TU Delft | Global Initiative. “To make sense of our design work we need to work together with all the other disciplines around us.”

We will follow the progress of the students in the coming weeks and share their insights. Stay tuned!

Contact

Want to learn more about this project or other TU Delft | Global Initiative or LUMC Global projects? You can contact us respectively through delftglobal@tudelft.nl or global@lumc.nl


More news & updates

Background Image Of A Scientist Recording Test Results In A Lab

Janssen COVID-19 vaccine approved for use in EU on March 11

March 11, 2021

The Janssen-Cilag International N.V COVID-19 vaccine has received authorization for emergency use by the European Medicines Agency (EMA) on March 11. Developed with fundamental support from the Molecular Virology group of the Leiden University Medical Centre (LUMC), it is the fourth vaccine to be administered in the European Union. The Netherlands has ordered more than 11 million vaccine doses.

Studying abroad during a pandemic

July 15, 2021

For many students from the LUMC’s academic programmes, studying abroad is an indispensable experience. Doing part of your studies abroad is a special experience, not only because of the sense of adventure of being abroad, also to develop a broader perspective on Life Sciences & Health, a highly international field. So, you can imagine the LUMC’s International Office’s struggle to have to tell students ‘no’ for a study experience abroad in the midst of the corona pandemic. In addition, the many lockdowns worldwide increased the workload dramatically for the International Office. Evelien Hack, Head of the International Office and Sandra van Deursen, senior administrative assistant, share how corona has impacted studying abroad.

Body cells under a microscope. A good illustration as a representation of research of stem cells, cellular therapy and regeneration and many other concepts. 3D illustration

LUMC and Ixaka announce collaboration to advance cell therapy development

March 30, 2021

The Leiden University Medical Center (LUMC) and Ixaka Ltd. have announced a research collaboration on 30 March 2021, to better understand REX-001, Ixaka’s lead cell therapy product. The project will be led by Professor Paul Quax, Head of Experimental Vascular Surgery at the LUMC, to support accelerated development of REX-001 in Phase III clinical trials for the treatment of chronic limb-threatening ischemia (CLTI).

Stay up to date with news, inspirations and events.

© LUMC Global. All rights reserved. Website door philogirl

Contact

Social